Recap: Amryt Pharma Q3 Earnings

Amryt Pharma AMYT reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Amryt Pharma missed estimated earnings by 20.0%, reporting an EPS of $-0.06 versus an estimate of $-0.05.

Revenue was up $4.61 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 1.29% increase in the share price the next day.

Here's a look at Amryt Pharma's past performance:

 

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -0.05 -0.02 -0.15 -0.17
EPS Actual -0.02 -0.05 -0.07 -0.07
Revenue Estimate 64.23M 58.12M 56.81M 52.78M
Revenue Actual 68.54M 59.13M 54.83M 56.52M

To track all earnings releases for Amryt Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!